Articles Tagged With:
-
Report: Still Not Enough Women Included in Cardiovascular Research
To augment the enrollment of women in cardiovascular trials, researchers must build awareness of cardiovascular risk factors and foster trust among women. Try increasing the percentage of women who lead clinical trials, modifying inclusion and exclusion criteria, and advertising the risks and benefits of participation to the general population.
-
IRBs Now Expect More Diversity in Research Trials
Promoting equitable participation must not be at the cost of impeding research. But within an ethical framework beyond regulations, IRBs are evolving to address and accelerate equitable inclusion in research.
-
Approaches to the Hemorrhaging Pediatric Trauma Patient
Clinicians might be surprised to learn that after central nervous system injury, hemorrhage/hemorrhagic shock is the second most common injury complex resulting in death for pediatric trauma patients. A thorough understanding of subtle presentations and management is essential to improve the outcome for these children.
-
Reproductive Health Is Important Among Communities with Opioid Use Disorder
Pregnancy-capable individuals with a history of opioid use disorder (OUD) hold an inherent distrust of the healthcare system. This is one reason why contraceptive counseling could be a challenge for this population. New research through Boston Medical Center shows that individuals with OUD exhibit similarities to individuals with other chronic medical conditions when they are choosing a contraceptive method. -
Research Shows Ultrasound Is Not Necessary for Medication Abortion
Researchers suggest reproductive health providers could offer patients a faster, less expensive medication abortion via telemedicine. Study findings show that omitting the pre-abortion ultrasound does not appear to compromise safety or result in more ongoing pregnancies. -
What Is New in Contraception?
The new editions of Contraceptive Technology and Managing Contraception include important updates to several forms of contraception, including progestin-only pills. -
Title X Program Saved by Biden Administration’s New Final Rule
Title X organizations and other groups praised the Biden administration for reversing the draconian changes to the Title X family planning program that were enacted in 2019 under the Trump administration. -
Effects of Texas Abortion Law Could Ripple Nationwide
The recent Texas law that banned abortions after six weeks gestation was written to be enforced by almost anyone, anywhere in the United States — creating a bounty hunter system. It could turn neighbors against neighbors, family members against family members, and incentivize strangers to spy on women. -
Safe and Legal Abortion Access Under Greatest Threat Since Roe v. Wade Decision
The largest and most damaging crack in the Roe v. Wade bulwark of abortion access was breached Sept. 1, when the U.S. Supreme Court’s inaction allowed the state of Texas to ban abortions after six weeks of gestation. There are no exceptions for rape or incest. The law gives about any person in the nation the right to sue the abortion provider and anyone else who assisted someone with abortion care. -
Difelikefalin Injection (Korsuva)
Difelikefalin can be prescribed to treat moderate-to-severe pruritus associated with chronic kidney disease in adults undergoing hemodialysis.